The INVIRASE brand, founded in 1994 (Switzerland), from 640 sister brands and 17477 competing brands. INVIRASE is a brand of ROCHE HOLDING, listed on the stock exchange of Zurich. The International Securities Identification Number (ISIN) of ROCHE HOLDING is CH0012032048. The sector of INVIRASE is Drug Manufacturers.

INVIRASE is a brand of ROCHE HOLDING (ROG) Share price

International deposit : 1994 Business sector Drug Manufacturers

Share price and profitability of the share ROCHE HOLDING (INVIRASE)

Buy ROCHE HOLDING share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 221.00

Portfolio valuation
ROCHE HOLDING (INVIRASE) over 5 years* CHF 182.23

Stock market history ROCHE HOLDING (INVIRASE)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ROCHE HOLDING

CARMOT THERAPEUTICS
CARMOT THERAPEUTICS
Telavant
Telavant
STRATOS GENOMICS
STRATOS GENOMICS
Promedior
Promedior
VIEWICS
VIEWICS
FLATIRON HEALTH
FLATIRON HEALTH
See more brands of ROCHE HOLDING

Rival brands
INVIRASE

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS